News from NYU Langone Health
Suffolk County News
In a Q&A for Heart Month, Emmanuel N. Moustakakis, MD, director of Inpatient Cardiology at NYU Langone Hospital-Suffolk, and Jonathan Weinstein, DO, FACC, director, Cardiac Catheterization Laboratory at NYU Langone Health and NYU Langone Hospital-Suffolk, emphasized that most heart disease is modifiable through lifestyle changes. They identified high blood pressure, cholesterol, diabetes, smoking, and obesity as the biggest drivers of heart disease. To combat this, they recommend a diet rich in fruits, vegetables, and lean proteins, and at least 150 minutes of moderate exercise per week. They also stressed the importance of knowing your numbers, managing stress, getting enough sleep, and seeing a primary care doctor annually. For heart attack symptoms, they noted it's not always crushing chest pain and can include discomfort in the jaw, neck, or arms, and urged calling 911 immediately.
Also reporting was:
2/18/2026
Women's Health
Platelet-rich plasma (PRP) therapy is gaining popularity for various conditions like pain relief and hair growth, though its effectiveness is inconsistent and it is not regulated by the FDA. The treatment, which can cost up to $1,500 per session, is not typically covered by insurance. Lauren E. Borowski, MD, a primary care sports medicine specialist at the NYU Langone Sports Medicine Center, notes that she performs three to five PRP injections weekly at the NYU Langone Sports Medicine Center for issues like knee arthritis. She adds that the therapy should always be used in conjunction with rehabilitation.
2/17/2026
MadameNoire
Medical experts are raising concerns that GLP-1 medications like Ozempic and Wegovy may lead to restrictive eating disorders. Thea Gallagher, PsyD, clinical associate professor and director of Wellness Programs in the Department of Psychiatry at NYU Langone Health, cautioned that the drugs' appetite-suppressing effects can be a 'slippery slope.' She explained that for individuals with restrictive eating disorders, the desire to not feel hungry makes the medication's effects particularly dangerous. Dr. Gallagher also noted that she has treated patients with eating disorders who bypassed safeguards to obtain the drugs, for instance by lying about their weight to get a prescription.
2/18/2026
TechTarget
The article outlines six strategies for training clinicians on AI clinical decision support tools. Paul A. Testa, MD, chief health informatics officer at NYU Langone Health, explains that NYU Langone Health first runs AI tools in the background for months to observe their behavior. He notes that dismissal rates for AI alerts dropped once clinicians understood the reasoning behind the recommendations. The health system also holds 'prompt-a-thons' to allow clinicians to experiment with new AI models using blinded patient data.
2/17/2026
Targeted Oncology
The focus in oncology has shifted from survival to long-term wellness, with 70% of cancer patients now reaching the 5-year survival mark due to advances in targeted treatments and immunotherapies. According to Marleen Meyers, MD, breast medical oncologist and director of the Cancer Survivorship Program at NYU Langone鈥檚 Perlmutter Cancer Center, clinicians now expect patients to survive. This necessitates a new focus on ensuring the best possible quality of life. Dr. Meyers asserts it is no longer acceptable for survival to come at the cost of permanent, life-altering conditions like infertility or cardiovascular disease.
2/18/2026
Quanta Magazine
Research on cellular biophysics reveals how crowded environments inside cells are crucial for biochemical reactions. Liam J. Holt, PhD, cell biologist at NYU Langone Health, uses genetically engineered nanoparticles to study this crowding. His work shows that cells actively regulate their internal density. Holt's team found that the nutrient sensor mTORC1 controls ribosome concentration, which directly impacts how crowded the cell is. This balance is essential for life, as too little crowding would slow reactions, while too much would halt them entirely.
2/18/2026
Running USA
New York Road Runners announced the professional athlete field for the United Airlines NYC Half, 麻豆视频入口d for Sunday, March 15. The lineup of local athletes includes Felicia Pasadyn, a full-time student at NYU Grossman School of Medicine. Pasadyn, who previously qualified for the 2020 U.S. Olympic Trials in swimming, qualified for the 2028 U.S. Olympic Trials Marathon during the 2025 TCS New York City Marathon. The race will feature all four defending champions and 30 Olympians and Paralympians.
2/17/2026
SCIENMAG
Researchers from NYU Langone Health have discovered a mechanism where aggressive tumors use the protein lipocalin 2 (LCN2) to evade the immune system. The study, published in *Nature*, found that cancer cells under stress secrete LCN2, which prevents T cells from attacking the tumor. An antibody developed to block LCN2 halted tumor growth in preclinical models and enhanced immunotherapy. The research, conducted at NYU Langone Health's Perlmutter Cancer Center, was led by Thales Papagiannakopoulos, PhD, associate professor in the Department of Pathology, and Shohei Koide, PhD, professor in the department of biochemistry and molecular pharmacology at NYU Grossman School of Medicine, and director of cancer biologics at the Perlmutter Cancer Center.
2/17/2026
Genetic Engineering & Biotechnology News
A preclinical study from NYU Langone Health researchers has shown how a protein called lipocalin 2 (LCN2) helps lung and pancreatic tumors evade the immune system. The research, led by Thales Papagiannakopoulos, PhD, associate professor in the department of pathology at NYU Grossman School of Medicine, found that blocking LCN2 slowed cancer growth in mice by enabling immune cells to target tumors. An antibody therapy targeting LCN2 shrank tumors and extended survival in mice, especially when combined with existing immunotherapy. According to co-author Shohei Koide, PhD, professor in the department of biochemistry and molecular pharmacology at NYU Grossman School of Medicine, and director of cancer biologics at the Perlmutter Cancer Center, the findings support developing LCN2-targeting therapies.
2/17/2026
Ex Bulletin
Researchers at NYU Langone Health are leading efforts to highlight the health hazards of microplastics. A review by Leonardo Trasande, MD, MPP, the Jim G. Hendrick, MD Professor of Pediatrics at NYU Grossman School of Medicine, linked plastic chemical exposure to risks like obesity, diabetes, and heart disease. His research also estimates that plastic-related childhood diseases cost the US $250 billion annually. Additionally, Taraneh Shirazian, MD, associate professor in the Department of Obstetrics and Gynecology and director of the Center for Fibroid Care, is studying the link between plastic chemicals and uterine fibroids. NYU Langone also hosted a symposium on the topic.
2/18/2026
MedPage Today
A nationwide cohort study from Sweden led by researchers including Jordan E. Axelrad, MD, MPH, associate professor in the Department of Medicine, Division of Gastroenterology and Hepatology at NYU Grossman School of Medicine, found that people with inflammatory bowel disease (IBD) and colorectal dysplasia are significantly more likely to develop colorectal cancer. The study of over 50,000 patients showed those with high-grade dysplasia had a nearly 50-fold higher odds of cancer. Ariela Holmer, MD, clinical assistant professor in the Department of Medicine, Division of Gastroenterology and Hepatology at NYU Langone, who was not involved, noted that these findings support strong consideration of colectomy for such patients.
2/17/2026
CURE Magazine
In an interview, Emeline M. Aviki, MD, MBA, a gynecologic oncologist and physician lead of the onco-fertility program at NYU Langone鈥檚 Perlmutter Cancer Center, discussed the expansion of fertility preservation options for cancer patients. She described novel techniques such as ovarian tissue cryopreservation and uterine transposition. Aviki highlighted that such advanced procedures are rare and noted that NYU Langone鈥檚 Perlmutter Cancer Center is one of the few specialized centers offering a comprehensive suite of these services. She also stressed the importance of early conversations about fertility and addressing nationwide shortcomings in patient access and navigation.
2/18/2026
PsyPost
New research suggests that the brain's structural wiring may influence how people solve problems through sudden insight, with less organized white matter linked to more frequent 'Aha!' moments. The article also discusses a separate study from researchers at NYU Langone Health that examined 'one-shot learning,' the visual equivalent of an epiphany. The NYU Langone Health study found that the high-level visual cortex uses stored memory templates to suddenly comprehend ambiguous visual information. Both studies highlight the brain's ability to reorganize information suddenly to form a coherent understanding.
2/19/2026
Hawaii Business
A bipartisan bill, the 鈥淓nd Kidney Deaths Act,鈥 aims to prevent kidney deaths by proposing a $50,000 tax credit for individuals who donate a kidney to a stranger. The legislation, which has 42 co-sponsors in the House, could save an estimated 100,000 lives and $40 billion over a decade. To address safety concerns, the article cites a study from NYU Langone Health spanning three decades, which found that by 2022, fewer than one in 10,000 kidney donors died within the first three months post-surgery. The bill is intended to increase the number of non-directed donors.
2/19/2026
